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Abstract 
Tumor growth strongly depends on the continuous blood and nutrients supply. 
Theoretically, it is an ideal therapeutic way of treating tumor by vascular embolization, 
which also reduces the harmful effects on surrounding normal tissues. However, most 
of the currently available vascular embolic agents are still rather insufficient in 
performances to fulfill the real clinical need due to the reasons like: incomplete filling 
of target vasculature, being easily washed away by blood or body solution, or just 
producing toxicity to human body. Here from an alternative way, the body 
temperature liquid metal, a kind of soft and highly compliant material, was proposed 
for the first time as a new conceptual blood vessel embolization strategy towards 
tumor physical therapy. With the unique capability of easy phase transition between 
liquid and solid state and sub-cooling behavior, such agent can be fluently injected 
into and to fully fill the tiny vessels including the ending capillaries. The in vitro 
cytotoxicity experiments have been performed which indicated that treating localized 
diseased tissues through liquid metal embolic agent is acceptable. Endowed with a 
high density, the liquid metal-filled vessels are highly visible under the CT scan, 
which offers the potential of the diagnosis-treatment integration with only one single 
material. To further demonstrate the new liquid metal vascular embolization therapy, 
several typical experiments in vivo on vasculatures of rabbit ears and mouse tails 
have been performed to provide the evidences of destroying the targeted tissues due to 
liquid metal filling. To interpret the liquid metal starvation therapy effects, theoretical 
model has been established to simulate the tumor growth with zero, partial or 
complete filling of the metal agent inside the vessels. All the results support that, 
given appropriate administration, the liquid metal embolization is able to destruct the 
target regions effectively and might be able to starve the tumors to death through a 
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relatively easy and compliant way. This study lays the foundation of a promising 
tumor starvation therapy with both high contrast image guidance capability and 
overall treatment outcome.   
 
Keywords:  Liquid metal; Tumor treatment; Blood vessel; Embolic agent; 
Starvation therapy; Diagnosis-therapy integration. 
 
 
1. Introduction 
Originated from somatic mutations, the tumor cells generally proliferate and 
differentiate continuously under the regulation of various growth factors as well as the 
oxygen and nutrients provided throughout the blood vessels [1-4]. At the early stage 
when the death and the regeneration of tumor cells are nearly balanced, the existing 
vascular network near the tumor tissues supplies nutrients and carries away 
metabolites. Afterwards, a new tumor vascular network generates around the tumor 
tissues due to the vascular endothelial growth factor secreted by the tumor cells [5]. 
Then, the rapidly increasing tumor cells would diffuse to other parts via the 
tumor-induced angiogenesis. Clearly, the blood vessels play a significant role on the 
growth and metastasis of the tumor [6].  
Considering the dependency of the tumor growth on the blood vessels, the 
treatment of vascular targeting therapy for starving the tumors to death has 
increasingly attracted the attentions of researchers across the world [7, 8]. One of such 
strategies is to prevent the tumor-induced angiogenesis by the angiogenesis inhibitors, 
which was originally proposed by Folkman in the early 1970s [9]. Ever since then, 
various inhibitive drugs have been developed [10-13], and such embolization therapy 
has also been combined with chemotherapy or radiotherapy for better treatment [14]. 
However, the angiogenesis inhibitors have to be used for a long time. And some 
studies found that within this period, the tumor itself would gradually generate 
resistance to these drugs, which makes it not as effective as expected [15]. As another 
approach focusing on blocking the existing vessels, colchicine was reported to destroy 
the vessels, yet with rather high toxicity [16]. Afterwards, some other vascular 
disrupting agents were studied including small molecular agents [17, 18].  
Except for these drugs, there are some other physical embolization ways to offer 
the possibility of starving the tissues or tumor to death by means of embolic agents, 
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such as autologous clots, coils, gelfoam, balloons, glue, nanoparticles, microspheres 
embolic agents and so on [19-23]. However, the failure to embolize the vessels may 
often occur. One key reason lies in that some solid embolic agents cannot conform 
well to the vessels, leaving certain space at the interface for nutrients to leak in. 
Another existing issue is that some embolic agents are easily rushed away by the 
blood flow, such as the balloons. What’s more, the catheters or other more complex 
equipments are needed in order to place some of embolic agents into the target 
positions. Different from these approaches, gas embolotherapy uses gas bubbles to 
occlude the blood flow [24]. The bubbles originate as small diameter liquid droplets 
of dodecafluoropentane (DDFP) mixed in saline and albumin. After injected into the 
vascular system, these droplets are small enough to pass through the capillary beds. At 
the strategic location, the droplets are vaporized into larger bubbles through acoustic 
wave to occlude flow. However, the entry of gas into the vessel system is a risk in 
virtually all areas of clinical care [25]. 
In view of the above tumor treatment situations, this paper is dedicated to 
proposing and demonstrating an alternative vascular embolization therapy, the body 
temperature liquid metal, as a kind of unconventional vessel embolic agent for 
starving the target tissues or tumors to death. Here, to emphasize the method itself, 
although plenty of liquid metal candidates can serve as the treatment agents, we 
mainly tested for the first trial the pure gallium and Ga75.5In24.5 alloy as the illustration 
examples. To characterize the physical behaviors of such metal agent, the DSC 
experiments on the liquid metal gallium were conducted, which revealed the thermal 
properties of the gallium and verified its feasibility for the delivery of therapy. The 
cytotoxicity of the gallium and indium in vitro were also evaluated with the tests of 
CCK-8 and flow cytometry. As an additional advantage, the liquid metal in vessels 
showed high image contrast under the X-ray scan, which indicated its great potential 
of the diagnosis-treatment integration. For further investigation, we experimented on 
several different tissues or transplanted tumor to demonstrate the liquid metal 
embolization effect in vivo. Finally, we presented the theoretical modeling and 
simulation of tumor growth affected by liquid metal enabled blockage of blood 
vessels near the tumor. This study opened the way of applying the liquid metal 
vascular embolization for a potential tumor starvation therapy in the coming time. 
 
2. Principle and methods 
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2.1  Basic feature of liquid metal vascular embolic therapy 
 
 
Figure 1  The principle illustration of liquid metal based tumor vascular embolization 
therapy. (a) The oxygen and nutrition supplies from the vessels to tissues without any embolic 
agents. (b) The incomplete occlusion. (c) The complete occlusion by the liquid metal. (d) The 
physical occlusion of the blood supply to tumor. (e) The liquid metal could be injected into or 
sucked out of the vessel in case of need. 
 
As a soft, compliant and fluidic material, the liquid metal can be easily injected 
and filled into the vessels and capillaries sufficiently, which stops the blood flow and 
all the related physiological events thus enabled because of its high density and 
fluidity. Fig. 1 illustrates the basic principle of the liquid metal embolization therapy 
and surgical operation of its injection and removal. As is widely known, tissues 
acquire oxygen and nutrition from the nearby feeding vessels (Fig. 1a). Though the 
vascular blockage can shut down the blood supply, yet the stream is still able to pass 
through the vessels interior when the embolic agent fails to completely occlude the 
vessels. As a result, the reduction of blood flow does not guarantee a strong enough 
effect on starving the necrotic cells (Fig. 1b) and the embolic agent can even possibly 
be rushed away within a short period after it was injected. Being able to maintain in 
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liquid state at body temperature, the liquid metal agent can easily shape itself along 
the vessels and fully occlude the channels due to its perfect compliance (Fig. 1c). 
Compared with the normal tissues, the tumor is more dependent on the nutrients 
supplies from the surrounding vessels. After injected into the vessels, the liquid metal 
results in a physical occlusion and thus leads to tumor regressions (Fig. 1d). Another 
merit of the current therapy still lies in that, theoretically, the liquid metal could also 
be well sucked out in case of need after completing its treatment role (Fig. 1e).  
 
2.2 Characterization of the physical properties of the liquid metal agents  
We measured the thermal property of gallium (99.999%, purchased from Anhui 
Rare New Materials Co. LTD, China) with the differential scanning calorimetry 
device (DSC 200 F3 Maia, Netzsch Scientific Instrument Trading Co. Ltd, Germany). 
The 14.63mg of gallium was put into the alumina crucible with another empty one as 
the reference, which were both placed in a heating furnace. The test temperature range 
included three cycles, which were set as 40°C → 60°C for 1min → -60°C for 1min → 
60°C for 1min → -60°C for 1min → 60°C for 1min → -60°C for 1min → 60°C for 
1min → 45°C → 70°C, and the heating and cooling rates were both prescribed at 
10°C /min. The results were analyzed by the software of NETZSCH Proteus Thermal 
Analysis. 
 
2.3 Evaluation of the metal agents cytotoxicity in vitro 
Two tests including the cell counting kit-8 (CCK-8) and the flow cytometry were 
applied on the mouse embryonic fibroblast cells (NIH3T3) to evaluate the 
cytotoxicity of the liquid metal.  
A drop of the gallium was put on the six-well plates filled with culture solution, 
soaking for 24 hours and 48 hours in the incubator. Meanwhile, a piece of polished 
and sterilized indium and copper were soaked under the same condition. 
CCK-8 method: Cells at logarithmic growth phase were treated by trypsin and 
tuned into single cell suspension with a concentration of 50000/ml, then seeded in a 
96-well plate with 100μL in each well. After being cultured for 24 hours, the cells 
were observed under the microscope and the samples in bad state were eliminated. 
The original culture solution was removed and the wells were washed with PBS 
solution. Then, the soaked solution of gallium, indium, copper and the original culture 
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solution (control group) were added into the wells with 5 parallel samples in each 
group. After being cultured for 24 hours, each well was washed and added with a 
mixture of 100μL fresh culture solution and 10μL CCK-8. The 96-well plate were put 
into the incubator for 2 hours, then optical density (OD) at 450nm wavelength were 
measured with multifunctional microplate reader (EnVision, USA PerkinElmer). The 
cell viability was calculated according the following equation: 
Cell viability= (OD-OD0)/ (ODc-OD0))              (1) 
where, ODc was the OD value of the control group and OD0 was the OD value of 
black wells without any cells. 
Flow cytometry method: The cells were seeded into the sterile dish of 60mm 
diameter with 300000 cells each. After cultured for 24 hours in the incubator, the 
original culture medium was removed and the wells were washed with PBS solution. 
Then, the three soaked solutions and the original culture solution were added 
separately. After cultured for another 24 hours, the cells in each dish were collected 
into the centrifuge tubes. By centrifuge at 1500r/min for 5min, the supernatant was 
removed and 1mL cell staining buffer and 5uL PI staining solution were added, then a 
30-min ice bath followed. Finally, the cell solution were placed in the flow cytometer, 
detecting the red fluorescence by flow cytometry (BD Calibur, the USA BD). 
 
2.4 Liquid metal angiography of the tumor vessels  
It was recently found that, different from other embolic agents, liquid metal has 
excellent visibility under the X-ray [26]. Thus in a further study, the tumor vessels 
injected with the liquid metal went through a CT scan to investigate the distribution of 
the material. In order to assess this special characteristic, several representative 
objects such as in vitro swine kidney, a healthy 8-week-old female CD1 mice and an 
8-week-old female Barb/c nude mice (purchased by the Center of Biomedical 
Analysis of Tsinghua University) with a tumor were selected to serve as the 
experimental testing cases. 
About 0.8mL liquid metal gallium was infused into the artery branches of the 
swine kidney. Then the filled kidney was X-ray photographed by a micro-CT scanner 
(XM-Tracer-130, from Institute of High Energy Physics, Chinese Academy of 
Sciences). 
The mouse has both arteries broad enough for liquid metal Ga75.5In24.5 alloy 
infusion and thin capillaries to display the alloy’s high contrast. First, the mouse was 
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excessively anesthetized to death, then the heart was exposed by cutting open its chest. 
A thin syringe needle was used to penetrate into the left ventricle of the mouse heart 
and it was clamped to prevent leakage and reverse flow. With a slight cut near the 
right atrium, the liquid metal alloy could finally be infused into the circulatory tunnels 
and flow throughout the body. When the silvery alloy flows to the right heart, it was 
supposed to finish the infusion and that the sample had been stuffed with the contrast 
agent. Then the sample was taken to the imaging instrument (Super Nova CT, from 
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences). Images 
with higher resolution were obtained from the micro-CT (XM-Tracer-130, from 
Institute of High Energy Physics, Chinese Academy of Sciences). 
The structures of the vessels in the tumor tissues and normal tissues may be 
different. In order to offer more evidences on various tissue vasculatures, we also 
managed to infuse the liquid metal Ga75.5In24.5 alloy into the tumor vessels. The mouse 
breast cancer cells (EMT6, 1x10
6
cells) were injected directly into the subcutaneous at 
the back of the nude mice. The tumor reached approximately a diameter of 5mm in 
two weeks and the vessels were visible on the skin. After the mice was anesthetized 
with intraperitoneal injection of 0.2mL 1% (g/L) sodium pentobarbital (Nembutal), 
the liquid metal was injected directly into a tumor vessel via a special syringe needle 
with an inner diameter of 0.3mm. Afterwards, the tumor region went under a CT scan 
(Super Nova CT, from Technical Institute of Physics and Chemistry, Chinese 
Academy of Sciences) for visualizing the vessels injected with liquid metal. 
 
2.5 Liquid metal as embolic agents of blood vessels in vivo 
A two-month-old male New Zealand rabbit (purchased from the Center of 
Biomedical Analysis of Tsinghua University), weighted about 2.2kg, were used as the 
experimental subject, because the vessels in the ears are broad and visible. 
Anesthetized with intraperitoneal injection of 4% (g/L) sodium pentobarbital 
(Nembutal) by the standard of 1 ml/kg, the rabbit was injected with liquid metal 
gallium into the vein of one ear. It was observed that the material filled the vessels at 
the rim and the tip of the ear quickly. The other ear was used for contrast. The infrared 
camera (Thermovision A40, FLIR, Wilsonville, OR) was adopted to record the 
temperature changes of the rabbit ear during the operational process. Afterwards, the 
rabbit was observed for half an hour and then put back to the caring center. The rabbit 
continued to be observed every day. Blood analysis were carried out before the 
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experiments and 1 day, 3 days, 7 days afterwards with the automatic hematology 
analyzer (BM800), each time with 3 repeated trials. After the occurrence of necrosis 
at the ear tip, the rabbit was sacrificed through standard procedure. Then the tissues of 
both the necrotic region and the same position of the other ear were surgically cut and 
immediately restored in formalin for 24 hours. The samples were then sectioned, 
stained with HE methods (Hematoxylin-eosin) and observed under the microscope.  
Afterwards, we injected the liquid metal gallium into the vessels of the mouse tail 
and the rabbit leg in the same way. All experiments above have been approved by the 
Ethics Committee of Tsinghua University, Beijing, China under contract [SYXK (Jing) 
2009-0022]. 
  
2.6 Theoretical modeling and simulation of tumor growth with liquid metal 
embolization 
Although the liquid metal embolization of blood vessels in vivo was implemented 
on the vessels of rabbit ears and legs, a case of tumor might be more illustrative. Here, 
a theoretical modeling and simulation of tumor growth affected by the metal blockage 
of blood vessels nearby was (see Fig. 2) carried out to interpret the starvation effect of 
the current therapy. 
 
 
 
Figure 2  Illustration of the theoretical tumor growth model. (a) Without the liquid metal in 
the vessel. (b) With the liquid metal embolic agent in the vessel. 
 
 Without losing any generality, there are generally four dependent variables to 
dominate the tumor growth model, including cancer cell density, oxygen density, 
extracellular matrix density and matrix degrading enzymes. The functions of each 
variable (further details about the functions could be seen in Alexander’s work [27]) 
in non-dimensional are expressed as 
9 
 
2 ( )n
n
d n n f
t


    
  
（2） 
2
o
o
d o f n o
t
  

    
  
（3） 
f
mf
t


 
  
（4） 
2
m
m
d m n m
t
 

   
  
（5） 
where n , o , f  denote the density of cells, oxygen and extracellular matrix 
respectively, and m denotes the matrix degrading enzymes. 
The oxygen is supplied by the vessel and we make the assumption that the 
oxygen concentration is zero at the metal blockage position. The probabilities of 
movement of an individual cell are generated by discretizing the Equation (2). 
 
Table 1  The non-dimensional parameter values used in the simulations 
Parameters Value Parameters Value 
nd   0.0005   1 
0d （out of /in the tumors） 0.05/0.025   0 
md  0.0005   0.5 
  0.01   0.57 
  50   0.025 
 
Besides, it is assumed that the cancer cells migrate through a combination of 
diffusion and haptotaxis as well as undergoing proliferation. And each cell is allowed 
to migrate when the number of neighbor cells is more than one. Cell death can occur 
due to lack of oxygen. In the model, we also make the assumption that each cell 
produces two daughter cells when the cell has reached maturity. If no empty space 
around the parent cell exists, the cell becomes quiescent until space appears. We 
assume that quiescent cells only consume half amount of oxygen of the active tumor 
cells. The tumor cells would not only maintain one phenotype, but also becomes more 
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unstable and more aggressive phenotypes due to mutations. In the model, we mainly 
consider three phenotypes. The irreversible mutations occur at the mitosis stage. 
The computation domain is divided by 200×200 grids with a space step of 
0.005h  and a time step of 0.0001k  . Initially, 36 tumor cells are in the center. The 
initial value of oxygen density, extracellular matrix density and matrix degrading 
enzymes are 1, 1 and 0, respectively. The non-dimensional parameter values used in 
the simulations are listed in Table 1 [27]. 
 
 
3. Results 
3.1 Physical properties of the liquid metal 
Fig. 3 depicts the DSC curves of the gallium in reciprocally reverse processes. In 
either the cooling or the heating process, the measurement goes for three trials and the 
results are almost identical. There is a very sharp exothermic peak over the cooling 
process, and the freezing temperature is 4.5 °C, while the endothermic peak is also 
steep in the heating process and the melting point is 28.3°C. The curves indicate an 
easy transition between the solid and liquid phase of the gallium, which is an 
excellent property for the phase control. What’s more, owing to its sub-cooling effect, 
the material is able to maintain in the liquid state for a long time at the body 
temperature. Thanks to its liquid phase, compliance and fluidity, the material is able to 
fluently flow into and fill the tiny vessels including the capillaries whose diameter is 
at a scale of micrometers.  
 
Figure 3  The DSC curves of the gallium. (a) Cooling process. (b) Heating process. 
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3.2 Cytotoxicity of the liquid metal in vitro 
Fig. 4a shows the viability of the cells after cultured in different metal soaked 
solutions with CCK-8 method. The cell viability in the copper soaked solution in 24 
hours was measured as 7%, and almost all died in 48 hours. The cell viability of the 
gallium soaked solution in 24 hours and 48 hours were 100.6% and 75.7%, and that of 
indium were 107% and 79.7%, respectively. According to the cytotoxicity evaluation 
criteria of the national standard, cell viability above 75% is qualified and safe. The 
viability of the cells can also be visually demonstrated through the microscope, which 
is shown in Fig. 4b. The cells of the gallium, indium soaked solution and original 
culture solution were exactly of the right size and shape large, while those in the 
copper soaked solution distributed sparsely and the shapes were relatively round, 
which means most of them were dead. 
 
 
Figure 4  Cytotoxicity in vitro. (a) The cell viability after cultured in different metal soaking 
solution with CCK-8 method. (b) The cellular morphology in each experimental group 
observed under the microscope. (c) The cell apoptosis with flow cytometry method. (d) The 
scatter images with flow cytometry method. 
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Fig. 4c indicates cell apoptosis of each experimental group. In the PI fluorescence 
intensity histograms, M1 stands for apoptosis cells while M2 represents living cells. 
Compared with the control group, the relative apoptosis rates of gallium and indium 
group was 10.18% and 7.9% respectively while 78.44% for the copper group. In the 
scatter images in Fig. 4d, it can be further found that the strength of forward scattered 
light reduced and the one side scattered light increased in the copper soaked solution, 
which also indicated that there were more apoptosis and necrosis cells. However, the 
gallium and indium group showed tiny difference with the control group. 
These experiments have revealed that the cytotoxicity of the gallium and indium 
ion are relatively low and their applications on localized severe disease treatment are 
clinically acceptable, given its unique values as will be revealed in later sections. 
 
3.3 Liquid metal angiography of the tumor vessels  
Endowed with a high density, the liquid metal is an excellent contrast agent for the 
vessel-like tissues under the X-ray [26], which is a unique advantage compared with 
most other embolic agents.  
The X-ray images of renal artery of the in vitro swine kidney are presented in Fig. 
5a. Clearly, a whole branch of the renal artery network is intact and the texture of the 
small vessels is rather clear. As shown in Fig. 5b, the vessels are separated with the 
other tissues obviously in highlight in the CT scan reconstruction of a whole-body 
infused mouse. In the image, it is easy to identify the liquid metal’s flow path 
throughout the carotid, limb and tail vessels even to the end tips. Besides, the 
branches in the lung, head and abdominal organs can also be distinguished with 
ultra-high contrast and clarity. In order to offer more evidence of the image guidance 
ability of the liquid metal alloy enhancement, Fig. 5c provides the closer X-ray 
photographs of vascular network in the abdomen of the mouse which has plenty of 
even tinier vessels. In the figure, the sensor focused in a square field with each side 
6.6mm long, and the resolution is thus set as 13μm/pixel. Accordingly, it can be 
referred to that the thinnest visible vessel is less than 30μm wide, which means a 
tremendous improvement of the blood vessel visualization. Besides, the tumor vessels 
filled with liquid metal are highly visible under the CT scan as expected. As can be 
seen, the tumarized vasculature appeares somewhat irregular (Fig. 5d) as compared 
with normal tissue vessels (Fig.5a). This clearly reflected the growth behavior of such 
diseased vessels. 
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Figure 5  The images of vessels filled with the liquid metal under the X-ray. (a) The X-ray 
image of renal artery of the in vitro swine kidney. (b) The top view of a liquid metal infused 
mouse in a whole-body CT scan and 3D reconstruction. (c) The X-ray image of vessels in the 
mouse abdomen with higher resolution. (d) 3D reconstruction image of tumor vessels. 
 
3.4 Liquid metal embolization to starve target living tissues to death 
As shown in Fig. 6a, the liquid metal has filled the rabbit ear vein at the rim and 
the tip. Without abnormal reactions, the rabbit showed obvious symptoms of necrosis 
only in the ear tip in three weeks, which finally come out like a dry leaf. The necrotic 
changes appeared not so serious at the rim of the ear, which might be due to the 
supply of certain surrounding tiny vessels. However, the very side of the ear had been 
crimped, which was a reflection of the liquid metal obstruction. 
As an attendant phenomenon, the temperature of the liquid metal obstructed 
region would decrease due to stop of the blood flow. As a special evaluation of the 
material’s influence, the temperature distributions in 0h, 24h, 48h and 72h from the 
thermal infrared images are depicted in Fig. 6b. Clearly, at the moment of the 
injection, the blood was immediately blocked, causing the temperature rise in the 
upstream and decrease in the downstream regions. With the time went on, the area of 
the low temperature region shrunk gradually, which indicated the concentration of the 
material to the tip. 
In order to provide a biological inspection, Fig. 6c displays the sections of both 
the necrotic and normal tissues. It can be seen that near the liquid metal blocked 
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vessels, the surrounding area tends to be emptier and the cells are much smaller than 
the situation in the similar region in a normal tissue. This shows the damage effect of 
the liquid metal embolization treatment.  
 
 
Figure 6  The effects of liquid metal embolization at the rabbit ears. (a) The symptoms of 
necrosis in the ear. (b) The temperature distribution changes after 0h, 24h, 48h and 72h. (c) 
Comparison between the necrosis tissue sections and control normal tissue section. (d) The 
results of WBC, LYM%, MON%, GRA%, HGB, RBC and PLT* changed over time. (e)WBC, 
RBC and PLT dynamic histograms distribution. 
*WBC: white blood cell; LYM: lymphocyte; MON: monocyte; GRA: granulocyte; HGB: 
hemoglobin; RBC: red blood cell; PLT: platelet. 
 
Other than the morphologic analysis, blood tests were also carried out in a week 
and seven parameters including WBC, LYM%, MON%, GPA%, HGB, RBC and PLT 
are shown in Fig. 6d. Fig. 6e shows the WBC, RBC and PLT dynamic histograms 
distribution, respectively. As can be seen from the figure, the second peak of WBC 
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distribution was lowered after one day but returned to normal after 3 days, which 
indicated the reduction of the neutrophil granulocytes. These blood analysis results 
demonstrated that the blood parameters would soon return to normal level after the 
liquid metal gallium was injected into the blood. 
 
 
 
Figure 7  The effects of liquid metal embolization at the mice tail. (a) The liquid metal 
injected into the tail vein. (b) The regenerated vascular branches.  
 
It should be pointed out that, not all the injections will be able to completely fill 
the vessels and thus lead to damage of the target tissues. The output in fact depends on 
the specific surgical injection and delivery of liquid metal. To explain this point, we 
select the tail vessels of the mice as an additional test object to evaluate the blockage 
effect of liquid metal embolization on the tissues in vivo. As shown in Fig. 7a, three 
tail vessels of the mice were filled with liquid metal gallium. However, there was no 
visible necrosis after three weeks later. Moreover, certain new small blood vessels 
were even observed to regenerate (Fig.7b). The reason can be interpreted as follows. 
With a single flow direction and different from former cases, it was more difficult in 
current situation to fully block the femoral vessels at the tail of the mice. This led 
some of the liquid metal to flow away and no visible necrosis occurs at the target 
tissues over the whole experiments. Besides, these regenerated blood vessels near the 
tail vessels have further contributed for the nutrition and oxygen supply. This reminds 
us that, without appropriate administration of injecting the liquid metal agent, the 
embolization effect as anticipated before may not always necessarily be guaranteed. 
Therefore, for therapeutic purpose, careful treatment planning should be made in 
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advance to surgically deliver liquid metal into the target vessels along specific 
directions. Lastly, it was also worth mentioning that these mice filled with liquid 
metal were kept alive for a rather long time like several weeks. Such findings indicate 
the safety and non-toxicity of the liquid metal materials staying inside the vessels on 
condition that they will not cause physically physiological danger.  
 
3.5 Theoretical results of tumor growth with liquid metal embolic agents 
Theoretical simulations on the two cases with and without liquid metal embolic 
agents in the vessels near the tumor have been implemented to interpret and evaluate 
the performance of tumor growth suppression by the present method. Fig. 8 depicts 
the changes of oxygen concentration near the tumor at six times (5 days, 9days, 
11days, 13days, 15days and 17days later). The tumor growth consumes oxygen and 
the oxygen concentration in tumor center is the lowest. In order to maintain growth, 
the tumor needs adequate oxygen supply by the vessel. However, as a result of liquid 
metal blockage in the vessel, the oxygen concentrations of the nearby tissues are 
decreasing. Fig. 9 shows the predicted results for tumor growth. Different color 
represents different phenotype cells, and red is the most aggressive cells. The tumor 
grows towards the vessel since there exists only one single vessel on one side. The 
tumor cell distribution shows a dead central region, which is due to lack of the oxygen 
as shown in Fig. 8. For the case without liquid metal embolic agent, the dead central 
region occures after the 17 days, while for the case with liquid metal embolic agent, 
the dead central region occurs after the 11 days. As the time goes on, the dead central 
regions continue to enlarge. 
 
 
 
Figure 8 The oxygen distribution with the change of time. (a) Without the liquid metal in the 
vessel. (b) With the liquid metal embolic agent in the vessel. 
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Figure 9  Spatial distribution of tumor cells with the time. (a) Without the liquid metal in 
the vessel. (b) With the liquid metal embolic agent in the vessel. 
 
4. Discussion  
As is well known, the abundant vessels in the tumor tissues make it difficult for 
tumor treatment. Curatie surgery can easily lead to a massive hemorrhage, and large 
blood vessels would produce localized cooling in heated tissues during tumor 
hyperthermia, for instance. In this study, body temperature liquid metal yields a 
promising injectable tumor treatment. With its easy phase conversion, such material 
owns the capability to flow into tiny vessels at liquid state and stay at the target 
tissues at the solid state. Once the liquid metal was injected into the vessels, the 
nearby tissues would be possibly starved to death due to cutting off the feeding route 
of the nutrition and oxygen supplies. 
Though the unprecedented application of the liquid metal on the tumor treatment 
seems to be beyond imagination, there remains a wide range for the further utilization 
of the material. In the present experiments, only gallium and Ga75.5In24.5 alloy were 
tested for brief. In fact, the melting points of the liquid metal could be modified by 
adding some other metals into alloys and adjusting the compounds ratio. 
As a metal, the gallium is endowed with good electrical and thermal conductivity. 
Hence on the base of the blocking therapy, newer treatment might still be developed 
through combining the electrical and thermal stimulation together. We could even add 
certain substances into the liquid metal to obtain or enhance specific properties. Ma 
and Liu proposed a method to fabricate liquid metal with desired properties by 
loading with nanoparticles [28]. These nanoparticles include magnetic oxides such as 
Fe3O4, metallic particles and some semi-conductive particles, which further expands 
the application of liquid metal as the embolic agents. What’s more, it is possible to 
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combine this approach with chemotherapy or radiotherapy by injecting mixed liquid 
metal with chemotherapy and radiotherapy substances. 
In this study, it is worth emphasizing the role of the liquid metal angiography, 
which reveals an extra advantage of the vessel blocking therapy. The visibility of the 
material under the X-ray has provided the possibility for monitoring the flow process 
along the gallium injection and evaluating vascular changes and damages. The 
combination of the liquid metal blocking and the X-ray imaging even opens a 
promising approach to the investigation of the tumor vessel growth and distribution, 
which also indicates a great potential of the diagnosis-treatment integration. 
However, there still exist many issues to be solved in order to further improve the 
efficiency of the liquid metal embolization. Considering the difficulties to inject the 
liquid metal into the artery due to fast blood flow there and deep position in the 
tissues, we almost administrated these experiments on the veins. However, as we all 
know, the blood in artery flows into the capillary vessel, while that in vein blood 
flows out of the capillary vessel. Therefore, it is better to inject the liquid metal into 
the artery to occlude the vessel. Besides, the regeneration of the tumor vessel network 
under the obstructive condition is also a common challenge in the blocking therapy. 
The safety is also a non-negligible issue in this new conceptual blood vessel 
embolization strategy. As mentioned above, some of the liquid metal could be washed 
away from the target tissues since injection from the veins. As is shown in Fig. 10, the 
liquid metal has entered the heart and lungs of the rabbit in the experiments of leg 
infusion yet the rabbit is still alive. Therefore it is very important to adopt measures to 
prevent this problem from happening in further studies. One possible solution is to 
apply proper pressure on the proximal end to slow the blood flow velocity. Another 
method to decrease the blood flow is to reduce the temperature of the blood in the 
target tissues, which could also speed up the solidification of the liquid metal. It also 
indicates that the in vivo application is highly sophisticated due to safety control and 
thus skilled surgical operation is required as well. In this paper, we only used gallium 
and Ga75.5In24.5 alloy as the embolic agents, whose melting point are both under the 
37°C. Next, we will try to synthetize more other liquid metal alloys with a little higher 
melting point than 37°C and test their embolization effects. In addition, a 
comprehensive evaluation of long-term toxicity still requests further research.  
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Figure 10  Traces of the liquid metal in the heart and lungs of the rabbit. 
 
 
5. Conclusion 
In summary, the liquid metal, as a fluidic material at body temperature, has been 
proposed for the first time as the blood vessel embolic agent to starve the necrotic 
tissues or target tumors to death. With its merits of easy phase transition and 
sub-cooling, this kind of material can be conveniently injected into the vessels with 
relatively easy operations. A series of in vitro experiments on the material 
cytotoxicity have been implemented to evaluate its safety and the results have 
indicated that both gallium and indium irons show low toxicity on normal cell growth. 
On considering its application against tumor or other severe diseases, such a 
performance is quite acceptable. As an extra advantage, the liquid metal is endowed 
with excellent contrast under the X-ray over the tissues, which provided a powerful 
soft tool for tumor vascular research and offered great potential to realize the 
diagnosis-treatment integration. Furthermore, both in vivo experiments and theoretical 
model simulations have preliminarily demonstrated the performance of the liquid 
metal to starve the tissues or tumors to death. Though still facing certain challenges, 
the unprecedented utilization of the liquid metal agent opens a new way for 
further practice in future tumor vessel blocking therapy. 
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